Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 1
2001 1
2003 2
2004 1
2005 2
2006 1
2007 1
2009 5
2010 4
2011 1
2012 2
2013 2
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Heparin derivatives as angiogenesis inhibitors.
Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Liekens S, Rusnati M. Presta M, et al. Among authors: leali d. Curr Pharm Des. 2003;9(7):553-66. doi: 10.2174/1381612033391379. Curr Pharm Des. 2003. PMID: 12570803 Review.
VEGFR2 activation mediates the pro-angiogenic activity of BMP4.
Rezzola S, Di Somma M, Corsini M, Leali D, Ravelli C, Polli VAB, Grillo E, Presta M, Mitola S. Rezzola S, et al. Among authors: leali d. Angiogenesis. 2019 Nov;22(4):521-533. doi: 10.1007/s10456-019-09676-y. Epub 2019 Jul 30. Angiogenesis. 2019. PMID: 31363885
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
Ronca R, Di Salle E, Giacomini A, Leali D, Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W, Presta M. Ronca R, et al. Among authors: leali d. Mol Cancer Ther. 2013 Dec;12(12):2760-71. doi: 10.1158/1535-7163.MCT-13-0487. Epub 2013 Oct 15. Mol Cancer Ther. 2013. PMID: 24130051
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2).
Morello E, Arena F, Malagola M, Farina M, Polverelli N, Cavagna E, Colnaghi F, Donna L, Zollner T, Accorsi Buttini E, Andreoli M, Ricci C, Leoni A, Samarani E, Bertulli A, Leali D, Bernardi S, Russo D. Morello E, et al. Among authors: leali d. Nutrients. 2022 Aug 31;14(17):3589. doi: 10.3390/nu14173589. Nutrients. 2022. PMID: 36079847 Free PMC article.
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.
Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M. Mitola S, et al. Among authors: leali d. Blood. 2010 Nov 4;116(18):3677-80. doi: 10.1182/blood-2010-06-291930. Epub 2010 Jul 21. Blood. 2010. PMID: 20660291 Free article.
A pro-inflammatory signature mediates FGF2-induced angiogenesis.
Andrés G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener RA, Christofori G, Alcamì A, Presta M. Andrés G, et al. Among authors: leali d. J Cell Mol Med. 2009 Aug;13(8B):2083-2108. doi: 10.1111/j.1582-4934.2008.00415.x. J Cell Mol Med. 2009. PMID: 18624773 Free PMC article.
26 results